Usefulness of paraclinical follow-up in stage I melanoma

被引：6

作者：

Bastien, M

Tessier, MH

Legoux, B

Litoux, P

Bureau, B

Dreno, B

机构：

来源：

ARCHIVES OF DERMATOLOGY | 1997年 / 133卷 / 11期

关键词：

D O I：

10.1001/archderm.133.11.1462

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1462 / 1463

页数：2

共 5 条

[1] ROLE OF COMPUTED-TOMOGRAPHY IN THE STAGING OF PRIMARY MELANOMA [J].

BUZAID, AC ;

SANDLER, AB ;

MANI, S ;

CURTIS, AM ;

POO, WJ ;

BOLOGNIA, JL ;

ARIYAN, S .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :638-643

[2] RESULTS OF ADJUVANT INTERFERON STUDY IN WHO MELANOMA PROGRAM [J].

CASCINELLI, N ;

BUFALINO, R ;

MORABITO, A ;

MACKIE, R .

LANCET, 1994, 343 (8902) :913-914

[3] PREDICTIVE VALUE OF STAGING INVESTIGATIONS IN PATIENTS WITH CLINICAL STAGE-I MALIGNANT-MELANOMA [J].

ISCOE, N ;

KERSEY, P ;

GAPSKI, J ;

OSOBA, D ;

FROM, L ;

DEBOER, G ;

QUIRT, I .

PLASTIC AND RECONSTRUCTIVE SURGERY, 1987, 80 (02) :233-247

[4] MELANOMA RECURRENCE SURVEILLANCE - PATIENT OR PHYSICIAN BASED [J].

SHUMATE, CR ;

URIST, MM ;

MADDOX, WA .

ANNALS OF SURGERY, 1995, 221 (05) :566-571

[5] UTILITY OF FOLLOW-UP TESTS FOR DETECTING RECURRENT DISEASE IN PATIENTS WITH MALIGNANT MELANOMAS [J].

WEISS, M ;

LOPRINZI, CL ;

CREAGAN, ET ;

DALTON, RJ ;

NOVOTNY, P ;

OFALLON, JR .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (21) :1703-1705

← 1 →